Abstracts tagged "osteoarthritis and work"

Abstract Number: 2263 • 2015 ACR/ARHP Annual Meeting
Construct and Convergent Validity of Four Global Measures of at-Work Productivity Loss in Patients with Rheumatic Diseases
Sarah Leggett¹, Diane Lacaille², Carina Mihai³, Mihai Bojinca⁴, Brendan van As⁵, Suzanne M. Verstappen⁶ and EULAR-PRO worker productivity group, ¹Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre,The University of Manchester, Manchester, United Kingdom, ²Arthritis Research Centre, University of British Columbia, Vancouver, BC, Canada, ³Internal Medicine and Rheumatology, Ion Cantacuzino Hospital, Bucharest, Romania, ⁴Carol Davila University of Medicine and Pharmacy, Internal Medicine and Rheumatology, Cantacuzino Hospital, Bucharest, Romania, ⁵Arthritis Research Canada, Richmond, BC, Canada, ⁶Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom
Background/Purpose: Several global measures are available to assess at-work productivity loss in rheumatic diseases. Paucity in research exploring the construct validity of such measures contributes…
Abstract Number: 1014 • 2013 ACR/ARHP Annual Meeting
Test-Retest Reliability Of Five Global Measures Addressing At Work Limitations/Productivity Loss In Patients With Rheumatological Conditions
Sarah Leggett¹, Annelies Boonen², Diane Lacaille³, Dorcas Beaton⁴, Bruno Fautrel⁵, Ailsa Bosworth⁶, Catherine Hoffstetter⁷, Sabrina Dadoun⁵, Carlo Alberto Scirè⁸, Sofia Hagel⁹, Mihai Bojinca¹⁰, Carina Mihai¹¹, Antje Neuen¹², Pam Rogers¹³, Denise Linton¹⁴, Ingemar Petersson¹⁵ and Suzanne Verstappen¹⁶, ¹Arthritis Research UK Epidemiology Unit, Manchester Academic Health Science Centre,The University of Manchester, Manchester, United Kingdom, ²Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, ³Rheumatology, Arthritis Research Centre of Canada, University of British Columbia, Richmond, BC, Canada, ⁴Scientist, Institute for Work & Health, Toronto, ON, Canada, ⁵APHP, Pitié-Salpêtrière University Hospital, Paris, France, ⁶National Rheumatoid Arthritis Society, Maidenhead, United Kingdom, ⁷Patient partner, Toronto, ON, Canada, ⁸Epidemiology Unit -Italian Society for Rheumatology, Milano, Italy, ⁹Department of Clinical Sciences Lund, Section for Rheumatology, Lund, Lund University and Skåne University Hospital, Lund, Sweden, ¹⁰Internal Medicine, “Dr. I. Cantacuzino” Hospital, Bucharest, Romania, ¹¹Department of Internal Medicine and Rheumatology, Dr.I.Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, ¹²University Hospital Maastricht, Internal Medicine, Division of Rheumatology, Maastricht, Netherlands, ¹³Rheumatology, Arthritis Research Centre, Vancouver, BC, Canada, ¹⁴Mobility Clinical Research Unit, St. Michael's Hospital, Toronto, ON, Canada, ¹⁵Lund University, Department of Orthopedics, Clinical Sciences Lund, Lund, Sweden, ¹⁶Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, United Kingdom
Background/Purpose: There are a number of single item global measures available to explore at-work productivity loss (presenteeism) in patients with rheumatological conditions. However, test-retest data…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].